We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
+12.45%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$347M
AUM Growth
+$7.88M
Cap. Flow
-$19.3M
Cap. Flow %
-5.56%
Top 10 Hldgs %
67.41%
Holding
160
New
5
Increased
32
Reduced
31
Closed
22

Sector Composition

Rank Sector Weight
1 Communication Services 42.12%
2 Consumer Discretionary 11.91%
3 Healthcare 9.88%
4 Energy 7.17%
5 Real Estate 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLD
151
DELISTED
Audentes Therapeutics, Inc
BOLD
-2,000
Closed -$60K
SEP
152
DELISTED
Spectra Engy Parters Lp
SEP
-18,212
Closed -$613K
AVXS
153
DELISTED
AveXis, Inc. Common Stock
AVXS
-24,327
Closed -$3.01M
MULE
154
DELISTED
MuleSoft, Inc.
MULE
-1,530
Closed -$67K
NLSN
155
DELISTED
Nielsen Holdings plc
NLSN
-19,665
Closed -$625K
ATVI
156
PUT
DELISTED
Activision Blizzard
ATVI
-57,307
Closed -$311K

Similar funds

ArchPoint Investors's Q2 2018 Portfolio in Review

As of Q2 2018, ArchPoint Investors held 160 positions worth $347M, up 2.3% from $339M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

ArchPoint Investors withdrew a net $19.3M in Q2 2018, closing 22 positions and reducing 31 holdings. Its most notable exit was Northrop Grumman, an estimated $4.23M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, ArchPoint Investors opened a new position in Global X MSCI Greece ETF worth $3.36M.

  • ArchPoint Investors's largest Q2 2018 buy was Global X MSCI Greece ETF: 122,804 shares worth $3.36M.
  • ArchPoint Investors added most to Global Blood Therapeutics, Inc. in Q2 2018, an estimated $3.77M increase.
  • ArchPoint Investors's biggest Q2 2018 reduction was VanEck Russia ETF, cutting an estimated $5.39M.
  • ArchPoint Investors fully exited Northrop Grumman in Q2 2018, selling an estimated $4.23M.
  • ArchPoint Investors's ten largest holdings make up 67% of its $347M portfolio in Q2 2018.
  • ArchPoint Investors opened 5 new positions and closed 22 in Q2 2018.
  • ArchPoint Investors's portfolio value rose 2.3% quarter-over-quarter to $347M.

Based on ArchPoint Investors's 13F filing for Q2 2018, filed 14 Aug 2018.